Mutated ERBB4: a novel drug target in metastatic melanoma?
Kurppa
Kari
K
Elenius
Klaus
K
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008545:Melanoma / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D009154:Mutation; D009362:Neoplasm Metastasis; D066247:Receptor, ErbB-4; D012878:Skin Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000473:pathology
D000970:Antineoplastic Agents; C587689:ERBB4 protein, human; D066246:ErbB Receptors; D066247:Receptor, ErbB-4